Tag: Heart / Stroke-Related: Coronary-Artery Disease
Availability of CVD Meds Varies by Low-Cost Generic Program
Variation in coverage seen by program, drug, and cardiovascular disease condition
Aspirin Underused in Secondary Prevention of Cardiovascular Disease
Estimates of use increased from 16.6 percent in low-income countries to 65.0 percent in high-income countries
Heterogeneity Found in Appropriate Use Criteria for Imaging of CAD
CMS-qualified AUC for coronary artery disease heterogeneous, sometimes conflict with respect to appropriateness
Coronary Heart Disease Mortality Dropped From 1990 to 2019
Half of all CHD deaths could have been prevented with elimination of smoking, alcohol, and obesity
Recommendations Developed for Chronic Coronary Disease
Team-based, patient-centered care emphasized, which considers social determinants of care and linked costs
P2Y₁₂ Inhibitor Monotherapy Better Than Aspirin in Coronary Artery Disease
Reduced risk seen for composite of cardiovascular death, myocardial infarction, and stroke
Adults With Coronary Artery Disease Not Meeting Cholesterol Targets
Three in four do not meet American guideline recommendations
CVD Risk Factors Predict Risk of Common Musculoskeletal Disorders
Authors found 17-fold increased risk for four or more MSDs and say findings point to need to prioritize cardiovascular health improvement
Ultrahigh-Resolution CCTA Has High Diagnostic Accuracy for Coronary Artery Disease
In a recent study, AUC of ultrahigh-resolution photon-counting coronary CT angiography was 0.93 per participant for detection of coronary artery disease
Elevated Lipoprotein(a) Predictor of Recurrent Coronary Heart Disease
Lp(a) of 500+ and 300+ mg/L versus lower significantly predicted recurrent CHD, with hazard ratios of 1.59 and 1.37, respectively
